RxDoctor Payments Data

Susan Chlebowski, MD

Child & Adolescent Psychiatry · Wampsville, NYNPI 1508878521

Payments from drug & device makers

$258in general payments, 2019–2025

Across 18 payments — averaging $14.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$69
  • Sunovion Pharmaceuticals Inc.$50
  • Neurocrine Biosciences, Inc.$42
  • Otsuka America Pharmaceutical, Inc.$38
  • Ironshore Pharmaceuticals Inc.$28
  • E.r. Squibb & Sons, L.L.C.$20
  • plus $11 from 1 others

What the payments were for

  • Food & beverage$258100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$258 in reported general payments places this provider in the 55th percentile of 317 child & adolescent psychiatry providers in New York.

See all child & adolescent psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$110,223
Medicare patients
243
Services billed
1,094

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate82$210,245
RexultiBrexpiprazole34$57,614
Abilify MaintenaAripiprazole23$54,711
Aripiprazole531$31,717
Lurasidone Hcl259$28,928
Ziprasidone Hcl223$14,579
Fluoxetine Hcl785$12,635
Quetiapine Fumarate539$12,414
Paliperidone ErPaliperidone82$12,337
TrintellixVortioxetine Hydrobromide23$11,592
Divalproex Sodium ErDivalproex Sodium204$11,508
Clozapine180$10,540
Fluvoxamine Maleate ErFluvoxamine Maleate20$10,243
Fluvoxamine Maleate151$9,590
Ritalin LaMethylphenidate Hcl12$9,132

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$38$112,32557 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 317 child & adolescent psychiatry providers in New York.

Other child & adolescent psychiatry in Wampsville

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →